150452-18-9Relevant academic research and scientific papers
Phosphodiesterase inhibitor compounds and nitric oxide donors
-
Page/Page column 23, (2008/06/13)
The invention provides phosphodiesterase inhibitors and/or nitric oxide donors that are useful in treating male impotence, female sexual dysfunction and anal diseases.
Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
-
, (2008/06/13)
The invention provides methods for treating female sexual dysfunctions by administering to a female individual a therapeutically effective amount of at least one compound that donates, transfers or release nitrogen monoxide, that induces the production of
4-aminoquinazoline derivative cGMP-PDE inhibitors for the treatment of erectile dysfunction
-
, (2008/06/13)
4-aminoquinazoline derivatives which are selective inhibitors of cGMP PDE are useful in the treatment of erectile dysfunction (impotence) in male animals, including man.
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
-
, (2008/06/13)
The present invention describes novel nitrosated and/or nitrosylated phosphodiesterase inhibitors, and novel compositions containing at least one nitrosated and/or nitrosylated phosphodiesterase inhibitor, and, optionally, one or more compounds that donat
Anti-ischemic 2,4-diaminoquinazolines
-
, (2008/06/13)
The invention is directed to certain 2,4-diaminoquinazoline compounds, their pharmaceutically acceptable salts, the pharmaceutical compositions comprising those compounds and their therapeutic methods of use. The compounds possess anti-ischemic activity.
